Canaccord maintains Buy rating, $101 target on Globus Medical stock
Canaccord Genuity maintained a Buy rating with a $101.00 price target for Globus Medical (NYSE:GMED) shares, which currently trades at $88.54. The firm's analysis supports the company's ongoing ...
BTIG maintains $91 target on Globus Medical stock post-acquisition
Globus Medical Inc. (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an "GREAT" financial health rating according to InvestingPro, reaffirmed its commitment to ...
7 of the Best Soft Mattresses of 2025
This soft mattress also has a "progressive support" design for all the layers, which is firm and soft where your body needs ...
Coupang Stock Meets 80-Plus RS Rating Benchmark
Rating upgraded from 74 to 81 Thursday. Coupang stock recently reclaimed its 50-day moving average and is trying to complete ...